DSC Advisors’s Elevance Health ELV Stock Holding History

DSC Advisors’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-454	Closed	-$219K	–	105
2022 Q2	$219K	Sell	454 -1	-0.2%	-$495	0.22%	103
2022 Q1	$224K	Buy	+455	New	+$208K	0.08%	115
2016 Q4	–	Sell	-45,496	Closed	-$5.7M	–	59
2016 Q3	$5.7M	Sell	45,496 -144	-0.3%	-$18.6K	3.46%	9
2016 Q2	$5.99M	Buy	45,640 +511	+1%	+$69.9K	3.77%	9
2016 Q1	$6.27M	Buy	45,129 +129	+0.3%	+$17.2K	3.73%	11
2015 Q4	$6.28M	Sell	45,000 -118	-0.3%	-$16.3K	3.28%	11
2015 Q3	$6.32M	Buy	45,118 +118	+0.3%	+$17.7K	3.07%	10
2015 Q2	$7.39M	Hold	45,000	–	–	3.84%	8
2015 Q1	$6.95M	Hold	45,000	–	–	3.69%	7
2014 Q4	$5.66M	Hold	45,000	–	–	3.28%	6
2014 Q3	$5.38M	Hold	45,000	–	–	2.71%	13
2014 Q2	$4.84M	Hold	45,000	–	–	2.6%	13
2014 Q1	$4.48M	Hold	45,000	–	–	2.21%	13
2013 Q4	$4.16M	Hold	45,000	–	–	2.03%	16
2013 Q3	$3.76M	Hold	45,000	–	–	2.39%	15
2013 Q2	$3.68M	Buy	+45,000	New	+$3.37M	2.44%	14

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

DSC Advisors's ELV Position: Q3 2022 in Review

DSC Advisors sold out of Elevance Health (ELV) in Q3 2022, closing a stake of 454 shares — an estimated $219K sold.

DSC Advisors first reported a position in ELV in Q2 2013 and held it in 16 quarters. The position peaked at $7.39M in Q2 2015. 1,447 funds tracked by Wall St. Rank hold ELV as of Q3 2022.

DSC Advisors reported no remaining Elevance Health position as of Q3 2022 after selling out during the quarter.
DSC Advisors sold 454 Elevance Health shares in Q3 2022, an estimated $219K.
DSC Advisors first reported a position in Elevance Health in Q2 2013 and held it in 16 quarters.
DSC Advisors's Elevance Health position peaked at $7.39M in Q2 2015.
1,447 funds tracked by Wall St. Rank held Elevance Health as of Q3 2022.

Based on DSC Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.